Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilization. 2002

Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
Department of Gynaecology and Obstetrics, Reproductive Medicine Unit, Maternité du CHUV, CH-1011 Lausanne, Switzerland. marc.germond@chuv.hospvd.ch

OBJECTIVE To compare the efficacy and the tolerability of two different vaginal formulations of micronized progesterone, Ellios and Utrogestan, used for luteal phase support after an in vitro fertilization (IVF) cycle. METHODS Cohort study. METHODS Fertility center in a university hospital. PATIENT(S(: One hundred twenty-three women who underwent IVF/intracytoplasmic sperm injection (ICSI) stimulated cycles from October 1998 to March 2000, who had at least six follicles of > or =14 mm on the day of hCG administration. METHODS Patients received Ellios pessaries (2 times 200-mg pessary/day) or Utrogestan capsules (2 x 100-mg capsules, two times a day). Progesterone was administered from the day of oocyte pickup (day 0) until menses or up to 10 weeks in pregnant patients. METHODS Progesterone levels, pregnancy rate, and tolerability tested by patient questionnaire. RESULTS The progesterone levels on days 0, 9, 16 were not statistically different between the two formulations. The pregnancy rate were similar in groups 1 and 2 (25.5% vs. 18.6%), whereas tolerance was significantly better in group 1 versus group 2 (vaginal discharge: 43% vs. 82%). CONCLUSIONS The efficacy of the two formulations of progesterone is comparable, although the patient tolerance for Ellios is better.

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D005260 Female Females
D005307 Fertilization in Vitro An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro. Test-Tube Fertilization,Fertilizations in Vitro,In Vitro Fertilization,Test-Tube Babies,Babies, Test-Tube,Baby, Test-Tube,Fertilization, Test-Tube,Fertilizations, Test-Tube,In Vitro Fertilizations,Test Tube Babies,Test Tube Fertilization,Test-Tube Baby,Test-Tube Fertilizations
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000282 Administration, Intravaginal The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories. Administration, Vaginal,Drug Administration, Vaginal,Instillation, Vaginal,Intravaginal Administration,Vaginal Drug Administration,Vaginal Administration,Administration, Vaginal Drug,Administrations, Intravaginal,Administrations, Vaginal,Administrations, Vaginal Drug,Drug Administrations, Vaginal,Instillations, Vaginal,Intravaginal Administrations,Vaginal Administrations,Vaginal Drug Administrations,Vaginal Instillation,Vaginal Instillations

Related Publications

Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
October 1996, Human reproduction (Oxford, England),
Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
December 2009, Taiwanese journal of obstetrics & gynecology,
Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
January 2007, Fertility and sterility,
Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
January 2017, Ceska gynekologie,
Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
January 1997, Contraception, fertilite, sexualite (1992),
Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
October 2017, Human reproduction (Oxford, England),
Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
May 2017, Human reproduction (Oxford, England),
Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
January 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
February 2010, Fertility and sterility,
Marc Germond, and Paola Capelli, and Giuliana Bruno, and Sara Vesnaver, and Alfred Senn, and Nathalie Rouge, and J Biollaz
June 2022, Gynecologie, obstetrique, fertilite & senologie,
Copied contents to your clipboard!